{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T11:02:59Z","timestamp":1783508579451,"version":"3.55.0"},"reference-count":214,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T00:00:00Z","timestamp":1534809600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008605","name":"Indian National Science Academy","doi-asserted-by":"publisher","award":["SP\/YSP\/136\/2016-1063"],"award-info":[{"award-number":["SP\/YSP\/136\/2016-1063"]}],"id":[{"id":"10.13039\/100008605","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research","doi-asserted-by":"publisher","award":["SPM-07\/0512 (0223)\/2015-EMR-l"],"award-info":[{"award-number":["SPM-07\/0512 (0223)\/2015-EMR-l"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"DOI":"10.3389\/fgene.2018.00336","type":"journal-article","created":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T05:07:38Z","timestamp":1534828058000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":33,"title":["Emergence of Members of TRAF and DUB of Ubiquitin Proteasome System in the Regulation of Hypertrophic Cardiomyopathy"],"prefix":"10.3389","volume":"9","author":[{"given":"Ishita","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishant K.","family":"Varshney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameena","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,8,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.trsl.2017.10.012","article-title":"Tumor necrosis factor receptor-associated factor 6 as a nuclear factor kappa B-modulating therapeutic target in cardiovascular diseases: at the heart of it all.","volume":"195","author":"Abdullah","year":"2017","journal-title":"Transl. Res."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1186\/1478-811X-9-22","article-title":"RACK1 A multifaceted scaffolding protein: structure and function.","volume":"9","author":"Adams","year":"2011","journal-title":"Cell Commun. Signal."},{"key":"B3","doi-asserted-by":"publisher","first-page":"13353","DOI":"10.1074\/jbc.273.21.13353","article-title":"CD27, a member of the tumor necrosis factor receptor superfamily, activates NF-\u03baB and stress-activated protein kinase\/c-Jun N-terminal kinase via TRAF2, TRAF5, and NF-\u03baB-inducing kinase.","volume":"273","author":"Akiba","year":"1998","journal-title":"J. Biol. Chem."},{"key":"B4","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1242\/jcs.183954","article-title":"Ubiquitin chain diversity at a glance.","volume":"129","author":"Akutsu","year":"2016","journal-title":"J. Cell Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.bbamcr.2004.10.003","article-title":"Mechanism and function of deubiquitinating enzymes.","volume":"1695","author":"Amerik","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"B6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1042\/bse0410015","article-title":"E3 ubiquitin ligases.","volume":"41","author":"Ardley","year":"2005","journal-title":"Essays Biochem."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1083\/jcb.200402033","article-title":"Muscle ring finger protein-1 inhibits PKC\ud835\udf00 activation and prevents cardiomyocyte hypertrophy.","volume":"167","author":"Arya","year":"2004","journal-title":"J. Cell Biol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1161\/01.RES.83.6.629","article-title":"Rapid turnover of connexin43 in the adult rat heart.","volume":"83","author":"Beardslee","year":"1998","journal-title":"Circ. Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"8189","DOI":"10.1523\/JNEUROSCI.2218-08.2008","article-title":"Depletion of 26S proteasomes in mouse brain neurons causes neurodegeneration and Lewy-like inclusions resembling human pale bodies.","volume":"28","author":"Bedford","year":"2008","journal-title":"J. Neurosci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nrd3321","article-title":"Ubiquitin-like protein conjugation and the ubiquitin\u2013proteasome system as drug targets.","volume":"10","author":"Bedford","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"B11","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1158\/2159-8290.CD-11-0172","article-title":"A20 ubiquitin ligase\u2013mediated polyubiquitination of RIP1 inhibits caspase-8 cleavage and TRAIL-induced apoptosis in glioblastoma.","volume":"2","author":"Bellail","year":"2012","journal-title":"Cancer Discov."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1158\/1078-0432.CCR-06-1812","article-title":"A phase I\/II study of arsenic trioxide\/bortezomib\/ascorbic acid combination therapy for the treatment of relapsed or refractory multiple myeloma.","volume":"13","author":"Berenson","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nsmb.2780","article-title":"New insights into ubiquitin E3 ligase mechanism.","volume":"21","author":"Berndsen","year":"2014","journal-title":"Nat. Struct. Mol. Biol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/jcb.24669","article-title":"Disruption of tumor necrosis factor receptor associated factor 5 exacerbates pressure overload cardiac hypertrophy and fibrosis.","volume":"115","author":"Bian","year":"2014","journal-title":"J. Cell. Biochem."},{"key":"B15","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1093\/cvr\/cvn083","article-title":"Elevated p53 expression is associated with dysregulation of the ubiquitin-proteasome system in dilated cardiomyopathy.","volume":"79","author":"Birks","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1159\/000340050","article-title":"Severe heart failure after bortezomib treatment in a patient with multiple myeloma: a case report and review of the literature.","volume":"128","author":"Bockorny","year":"2012","journal-title":"Acta Haematol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"6482","DOI":"10.1038\/sj.onc.1204788","article-title":"Tumor necrosis factor receptor-associated factors (TRAFs).","volume":"20","author":"Bradley","year":"2001","journal-title":"Oncogene"},{"key":"B18","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1002\/cphy.c160024","article-title":"Ubiquitin ligases and posttranslational regulation of energy in the heart: the hand that feeds.","volume":"7","author":"Brown","year":"2017","journal-title":"Compr. Physiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"4586","DOI":"10.1073\/pnas.072647999","article-title":"Impaired cardiac hypertrophic response in calcineurin A\u03b2-deficient mice.","volume":"99","author":"Bueno","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B20","first-page":"2233","article-title":"TNF receptor-associated factor 6 (TRAF6) mediates the angiotensin-induced non-canonical TGF-\u03b2 pathway activation of c-kit+ cardiac stem cells.","volume":"7","author":"Cao","year":"2015","journal-title":"Am. J. Transl. Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/383443a0","article-title":"TRAF6 is a signal transducer for interleukin-1.","volume":"383","author":"Cao","year":"1996","journal-title":"Nature"},{"key":"B22","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1157\/13087900","article-title":"Cardiac hypertrophy: molecular and cellular events.","volume":"59","author":"Carre\u00f1o","year":"2006","journal-title":"Rev. Esp. Cardiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1093\/abbs\/gmq012","article-title":"MG132, a proteasome inhibitor, attenuates pressure-overload-induced cardiac hypertrophy in rats by modulation of mitogen-activated protein kinase signals.","volume":"42","author":"Chen","year":"2010","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1073\/pnas.91.7.2684","article-title":"Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway.","volume":"91","author":"Chen","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1128\/MCB.16.5.2445","article-title":"mdm-2 inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein.","volume":"16","author":"Chen","year":"1996","journal-title":"Mol. Cell. Biol."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-013-0338-0","article-title":"Vinexin-\u03b2 protects against cardiac hypertrophy by blocking the Akt-dependent signalling pathway.","volume":"108","author":"Chen","year":"2013","journal-title":"Basic Res. Cardiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1042\/CS20150619","article-title":"Tripartite motif 32 prevents pathological cardiac hypertrophy.","volume":"130","author":"Chen","year":"2016","journal-title":"Clin. Sci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.yexcr.2014.08.021","article-title":"Pioglitazone inhibits angiotensin II-induced atrial fibroblasts proliferation via NF-\u03baB\/TGF-\u03b21\/TRIF\/TRAF6 pathway.","volume":"330","author":"Chen","year":"2015","journal-title":"Exp. Cell Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1212\/01.wnl.0000192261.02023.b8","article-title":"The ubiquitin proteolytic system from a vague idea, through basic mechanisms, and onto human diseases and drug targeting.","author":"Ciechanover","year":"2006","journal-title":"Neurology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"12333","DOI":"10.1073\/pnas.172376399","article-title":"Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice.","volume":"99","author":"Condorelli","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1161\/CIRCULATIONAHA.106.637827","article-title":"Activation of the cardiac proteasome during pressure overload promotes ventricular hypertrophy.","volume":"114","author":"Depre","year":"2006","journal-title":"Circulation"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-014-0094-0","article-title":"Proteotoxic crisis, the ubiquitin-proteasome system, and cancer therapy.","volume":"12","author":"Deshaies","year":"2014","journal-title":"BMC Biol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1161\/CIRCHEARTFAILURE.112.000080","article-title":"Tumor necrosis factor receptor associated factor 2 signaling provokes adverse cardiac remodeling in the adult mammalian heart.","volume":"6","author":"Divakaran","year":"2013","journal-title":"Circ. Heart Fail."},{"key":"B34","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/nrc2731","article-title":"20 years studying p53 functions in genetically engineered mice.","volume":"9","author":"Donehower","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"B35","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1161\/CIRCRESAHA.115.306233","article-title":"TRAF6-mediated SM22\u03b1 K21 ubiquitination promotes G6PD activation and NADPH production, contributing to GSH homeostasis and VSMC survival in vitro and in vivonovelty and significance.","volume":"117","author":"Dong","year":"2015","journal-title":"Circ. Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1172\/JCI24178","article-title":"Protein kinase cascades in the regulation of cardiac hypertrophy.","volume":"115","author":"Dorn","year":"2005","journal-title":"J. Clin. Invest."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1089\/ars.2013.5823","article-title":"Targeting the ubiquitin-proteasome system in heart disease: the basis for new therapeutic strategies.","volume":"21","author":"Drews","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"B38","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s004410051315","article-title":"Sarcomeric myosin heavy chain is degraded by the proteasome.","volume":"296","author":"Eble","year":"1999","journal-title":"Cell Tissue Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1038\/ni.1638","article-title":"Function of TRADD in tumor necrosis factor receptor 1 signaling and in TRIF-dependent inflammatory responses.","volume":"9","author":"Ermolaeva","year":"2008","journal-title":"Nat. Immunol."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5513","article-title":"NEDD4 ubiquitinates TRAF3 to promote CD40-mediated AKT activation.","volume":"5","author":"Fang","year":"2014","journal-title":"Nat. Commun."},{"key":"B41","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1172\/JCI32827","article-title":"Myosin accumulation and striated muscle myopathy result from the loss of muscle RING finger 1 and 3.","volume":"117","author":"Fielitz","year":"","journal-title":"J. Clin. Invest."},{"key":"B42","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1073\/pnas.0611726104","article-title":"Loss of muscle-specific RING-finger 3 predisposes the heart to cardiac rupture after myocardial infarction.","volume":"104","author":"Fielitz","year":"","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1161\/01.CIR.0000164237.58200.5A","article-title":"Requirement of nuclear factor-\u03baB in angiotensin II\u2013and isoproterenol-induced cardiac hypertrophy in vivo.","volume":"111","author":"Freund","year":"2005","journal-title":"Circulation"},{"key":"B44","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1146\/annurev.physiol.65.092101.142243","article-title":"Cardiac hypertrophy: the good, the bad, and the ugly.","volume":"65","author":"Frey","year":"2003","journal-title":"Annu. Rev. Physiol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"8152","DOI":"10.1128\/MCB.00227-07","article-title":"Thioredoxin and TRAF family proteins regulate reactive oxygen species-dependent activation of ASK1 through reciprocal modulation of the N-terminal homophilic interaction of ASK1.","volume":"27","author":"Fujino","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"4051","DOI":"10.1113\/JP273607","article-title":"Proteasome dysfunction in cardiomyopathies.","volume":"595","author":"Gilda","year":"2017","journal-title":"J. Physiol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"14440","DOI":"10.1073\/pnas.251541198","article-title":"Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy.","volume":"98","author":"Gomes","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1161\/CIRCRESAHA.110.226928","article-title":"Multiple facets of NF-\u03baB in the heart: to be or not to NF-\u03baB.","volume":"108","author":"Gordon","year":"2011","journal-title":"Circ. Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.cardfail.2014.11.008","article-title":"Patterns of cardiac toxicity associated with irreversible proteasome inhibition in the treatment of multiple myeloma.","volume":"21","author":"Grandin","year":"2015","journal-title":"J. Card. Fail."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2016.00104","article-title":"Rapamycin inhibits cardiac hypertrophy by promoting autophagy via the MEK\/ERK\/Beclin-1 pathway.","volume":"7","author":"Gu","year":"2016","journal-title":"Front. Physiol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1016\/j.yexcr.2012.06.015","article-title":"Angiotensin II increases CTGF expression via MAPKs\/TGF-\u03b21\/TRAF6 pathway in atrial fibroblasts.","volume":"318","author":"Gu","year":"2012","journal-title":"Exp. Cell Res."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2018.00011","article-title":"Delineating crosstalk mechanisms of the ubiquitin proteasome system that regulate apoptosis.","volume":"6","author":"Gupta","year":"2018","journal-title":"Front. Cell Dev. Biol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3892\/mmr.2014.2968","article-title":"Cardiac hypertrophy: mechanisms and therapeutic opportunities.","volume":"9","author":"Gupta","year":"2007","journal-title":"Antioxid. Redox Signal."},{"key":"B54","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s00109-005-0691-z","article-title":"Role of the NF-\u03baB signaling cascade and NF-\u03baB-targeted genes in failing human hearts.","volume":"83","author":"Gupta","year":"2005","journal-title":"J. Mol. Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"H20","DOI":"10.1152\/ajpheart.00082.2005","article-title":"Inhibition of NF-\u03baB induces regression of cardiac hypertrophy, independent of blood pressure control, in spontaneously hypertensive rats.","volume":"289","author":"Gupta","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1074\/jbc.M306976200","article-title":"Cell type-specific expression of the I\u03baB kinases determines the significance of phosphatidylinositol 3-kinase\/Akt signaling to NF-\u03baB activation.","volume":"279","author":"Gustin","year":"2004","journal-title":"J. Biol. Chem."},{"key":"B57","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s12185-008-0139-7","article-title":"Acute severe cardiac failure in a myeloma patient due to proteasome inhibitor bortezomib.","volume":"88","author":"Hacihanefioglu","year":"2008","journal-title":"Int. J. Hematol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nm1729","article-title":"Protein kinase CK2 links extracellular growth factor signaling with the control of p27 Kip1 stability in the heart.","volume":"14","author":"Hauck","year":"2008","journal-title":"Nat. Med."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0189861","article-title":"Cardiac-specific ablation of the E3 ubiquitin ligase Mdm2 leads to oxidative stress, broad mitochondrial deficiency and early death.","volume":"12","author":"Hauck","year":"2017","journal-title":"PLoS One"},{"key":"B60","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1002\/j.1460-2075.1996.tb00504.x","article-title":"Cell type-specific inhibition of p53-mediated apoptosis by mdm2.","volume":"15","author":"Haupt","year":"1996","journal-title":"EMBO J."},{"key":"B61","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/387296a0","article-title":"Mdm2 promotes the rapid degradation of p53.","volume":"387","author":"Haupt","year":"1997","journal-title":"Nature"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1161\/HYPERTENSIONAHA.116.07392","article-title":"Ubiquitin-specific protease 4 is an endogenous negative regulator of pathological cardiac hypertrophy.","volume":"67","author":"He","year":"2016","journal-title":"Hypertension"},{"key":"B63","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.pharmthera.2017.03.001","article-title":"Emerging role of DUBs in tumor metastasis and apoptosis: therapeutic implication.","volume":"177","author":"He","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"B64","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1093\/cvr\/cvp226","article-title":"Proteasome inhibitors and cardiac cell growth.","volume":"85","author":"Hedhli","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"B65","doi-asserted-by":"publisher","first-page":"H1385","DOI":"10.1152\/ajpheart.00532.2008","article-title":"Proteasome inhibition decreases cardiac remodeling after initiation of pressure overload.","volume":"295","author":"Hedhli","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/nrm1983","article-title":"Regulation of cardiac hypertrophy by intracellular signalling pathways.","volume":"7","author":"Heineke","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1093\/eurjhf\/hft034","article-title":"Primary proteasome inhibition results in cardiac dysfunction.","volume":"15","author":"Herrmann","year":"2013","journal-title":"Eur. J. Heart Fail."},{"key":"B68","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/nrc1994","article-title":"Ubiquitin and ubiquitin-like proteins in cancer pathogenesis.","volume":"6","author":"Hoeller","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"B69","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0014-5793(97)01480-4","article-title":"Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53.","volume":"420","author":"Honda","year":"1997","journal-title":"FEBS Lett."},{"key":"B70","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1159\/000488230","article-title":"Deubiquitinase inhibitor auranofin attenuated cardiac hypertrophy by blocking NF-\u03baB activation.","volume":"45","author":"Hu","year":"2018","journal-title":"Cell Physiol. Biochem."},{"key":"B71","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1161\/HYPERTENSIONAHA.110.149963","article-title":"Tumor suppressor A20 protects against cardiac hypertrophy and fibrosis by blocking transforming growth factor-\u03b2\u2013activated kinase 1\u2013dependent signaling.","volume":"56","author":"Huang","year":"2010","journal-title":"Hypertension"},{"key":"B72","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/cr.2016.31","article-title":"Drugging the undruggables: exploring the ubiquitin system for drug development.","volume":"26","author":"Huang","year":"2016","journal-title":"Cell Res."},{"key":"B73","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.gene.2013.12.052","article-title":"Cardiac-specific Traf2 overexpression enhances cardiac hypertrophy through activating AKT\/GSK3\u03b2 signaling.","volume":"536","author":"Huang","year":"2014","journal-title":"Gene"},{"key":"B74","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-1-4614-5398-7_3","article-title":"\u201cTRIM proteins as RING finger E3 ubiquitin ligases,\u201d in","author":"Ikeda","year":"2012","journal-title":"Trim\/Rbcc Proteins Advances in Experimental Medicine and Biology"},{"key":"B75","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.cell.2008.02.043","article-title":"Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury.","volume":"133","author":"Imai","year":"2008","journal-title":"Cell"},{"key":"B76","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1006\/excr.1999.4733","article-title":"Tumor necrosis factor receptor-associated factor (TRAF) family: adapter proteins that mediate cytokine signaling.","volume":"254","author":"Inoue","year":"2000","journal-title":"Exp. Cell Res."},{"key":"B77","first-page":"993","article-title":"MDM2, an introduction.","volume":"1","author":"Iwakuma","year":"2003","journal-title":"Mol. Cancer Res."},{"key":"B78","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1177\/0961203314560424","article-title":"Increased Syk phosphorylation leads to overexpression of TRAF6 in peripheral B cells of patients with systemic lupus erythematosus.","volume":"24","author":"Iwata","year":"2015","journal-title":"Lupus"},{"key":"B79","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1503\/cmaj.120138","article-title":"Hypertrophic cardiomyopathy: diagnosis, risk stratification and treatment.","volume":"185","author":"Jacoby","year":"2013","journal-title":"Can. Med. Assoc. J."},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11267","article-title":"The ubiquitin E3 ligase TRAF6 exacerbates pathological cardiac hypertrophy via TAK1-dependent signalling.","volume":"7","author":"Ji","year":"2016","journal-title":"Nat. Commun."},{"key":"B81","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1161\/HYPERTENSIONAHA.115.05469","article-title":"Tumor necrosis factor receptor\u2013associated factor 3 is a positive regulator of pathological cardiac hypertrophy.","volume":"66","author":"Jiang","year":"2015","journal-title":"Hypertension"},{"key":"B82","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/378206a0","article-title":"Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53.","volume":"378","author":"Jones","year":"1995","journal-title":"Nature"},{"key":"B83","doi-asserted-by":"publisher","first-page":"36171","DOI":"10.1074\/jbc.M406638200","article-title":"NF-\u03baB is essential for induction of CYLD, the negative regulator of NF-\u03baB EVIDENCE FOR A NOVEL INDUCIBLE AUTOREGULATORY FEEDBACK PATHWAY.","volume":"279","author":"Jono","year":"2004","journal-title":"J. Biol. Chem."},{"key":"B84","doi-asserted-by":"publisher","first-page":"499","DOI":"10.4049\/jimmunol.0903534","article-title":"Akt contributes to activation of the TRIF-dependent signaling pathways of TLRs by interacting with TANK-binding kinase 1.","volume":"186","author":"Joung","year":"2011","journal-title":"J. Immunol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.molcel.2004.08.008","article-title":"TAB2 and TAB3 activate the NF-\u03baB pathway through binding to polyubiquitin chains.","volume":"15","author":"Kanayama","year":"2004","journal-title":"Mol. Cell."},{"key":"B86","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1146\/annurev-cellbio-101011-155739","article-title":"Cardiac regenerative capacity and mechanisms.","volume":"28","author":"Kikuchi","year":"2012","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1161\/01.RES.0000161999.86198.1e","article-title":"Increased collagen deposition and diastolic dysfunction but preserved myocardial hypertrophy after pressure overload in mice lacking PKC\ud835\udf00.","volume":"96","author":"Klein","year":"2005","journal-title":"Circ. Res."},{"key":"B88","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/978-1-4419-6676-6_6","article-title":"\u201cMechanism, specificity and structure of the deubiquitinases,\u201d in","author":"Komander","year":"2010","journal-title":"Conjugation and Deconjugation of Ubiquitin Family Modifiers Subcellular Biochemistry"},{"key":"B89","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/nrm2731","article-title":"Breaking the chains: structure and function of the deubiquitinases.","volume":"10","author":"Komander","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.molcel.2007.12.018","article-title":"The structure of the CYLD USP domain explains its specificity for Lys63-linked polyubiquitin and reveals a B box module.","volume":"29","author":"Komander","year":"2008","journal-title":"Mol. Cell."},{"key":"B91","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1253\/jcj.65.353","article-title":"Molecular mechanism of cardiac hypertrophy and development.","volume":"65","author":"Komuro","year":"2001","journal-title":"Jpn. Circ. J."},{"key":"B92","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/nature01802","article-title":"The tumour suppressor CYLD negatively regulates NF-\u03baB signalling by deubiquitination.","volume":"424","author":"Kovalenko","year":"2003","journal-title":"Nature"},{"key":"B93","doi-asserted-by":"publisher","first-page":"17140","DOI":"10.1073\/pnas.0903786106","article-title":"TRAF5 is a critical mediator of in vitro signals and in vivo functions of LMP 1, the viral oncogenic mimic of CD40.","volume":"106","author":"Kraus","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B94","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/387299a0","article-title":"Regulation of p53 stability by Mdm2.","volume":"387","author":"Kubbutat","year":"1997","journal-title":"Nature"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1681\/ASN.2006010083","article-title":"Protein degradation by the ubiquitin\u2013proteasome pathway in normal and disease states.","volume":"17","author":"Lecker","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"270","DOI":"10.5483\/BMBRep.2016.49.5.187","article-title":"Proteasome inhibitors attenuated cholesterol-induced cardiac hypertrophy in H9c2 cells.","volume":"49","author":"Lee","year":"2016","journal-title":"BMB Rep."},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029055","article-title":"Stretch-induced hypertrophy activates NFkB-mediated VEGF secretion in adult cardiomyocytes.","volume":"6","author":"Leychenko","year":"2011","journal-title":"PLoS One"},{"key":"B98","doi-asserted-by":"publisher","first-page":"3211","DOI":"10.1172\/JCI31757","article-title":"Atrogin-1 inhibits Akt-dependent cardiac hypertrophy in mice via ubiquitin-dependent coactivation of Forkhead proteins.","volume":"117","author":"Li","year":"2007","journal-title":"J. Clin. Invest."},{"key":"B99","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1096\/fj.10-160895","article-title":"Enhancement of proteasome function by PA28\u03b1 overexpression protects against oxidative stress.","volume":"25","author":"Li","year":"2011","journal-title":"FASEB J."},{"key":"B100","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1161\/circulationaha.114.011195","article-title":"Transforming growth factor \u03b2\u2013activated kinase 1 signaling pathway critically regulates myocardial survival and remodeling.","volume":"130","author":"Li","year":"2014","journal-title":"Circulation"},{"key":"B101","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1093\/abbs\/gmw025","article-title":"The role of autophagy in cardiac hypertrophy.","volume":"48","author":"Li","year":"2016","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"B102","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.yjmcc.2014.12.007","article-title":"Activation of the cardiac proteasome promotes angiotension II-induced hypertrophy by down-regulation of ATRAP.","volume":"79","author":"Li","year":"2015","journal-title":"J. Mol. Cell Cardiol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1007\/s00018-008-8090-6","article-title":"Polyubiquitin chains: functions, structures, and mechanisms.","volume":"65","author":"Li","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"B104","doi-asserted-by":"publisher","first-page":"H1712","DOI":"10.1152\/ajpheart.00124.2004","article-title":"NF-\u03baB activation is required for the development of cardiac hypertrophy in vivo.","volume":"287","author":"Li","year":"2004","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.bbagrm.2010.09.001","article-title":"The role of the proteasome in heart disease.","volume":"1809","author":"Li","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"B106","doi-asserted-by":"publisher","first-page":"672","DOI":"10.7150\/ijbs.11883","article-title":"Functions of autophagy in pathological cardiac hypertrophy.","volume":"11","author":"Li","year":"2015","journal-title":"Int. J. Biol. Sci."},{"key":"B107","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/S0195-668X(02)00829-1","article-title":"Molecular determinants of myocardial hypertrophy and failure: alternative pathways for beneficial and maladaptive hypertrophy.","volume":"24","author":"Lips","year":"2003","journal-title":"Eur. Heart J."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.bbrc.2016.08.100","article-title":"Ubiquitin-specific protease 14 regulates cardiac hypertrophy progression by increasing GSK-3\u03b2 phosphorylation.","volume":"478","author":"Liu","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B109","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1101\/gad.13.8.1015","article-title":"TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling.","volume":"13","author":"Lomaga","year":"1999","journal-title":"Genes Dev."},{"key":"B110","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1161\/CIRCRESAHA.111.300119","article-title":"Cezanne regulates inflammatory responses to hypoxia in endothelial cells by targeting TRAF6 for deubiquitinationnovelty and significance.","volume":"112","author":"Luong","year":"2013","journal-title":"Circ. Res."},{"key":"B111","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/S0008-6363(02)00232-8","article-title":"A proteasome inhibitor confers cardioprotection.","volume":"54","author":"L\u00fcss","year":"2002","journal-title":"Cardiovasc. Res."},{"key":"B112","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1084\/jem.20091293","article-title":"Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile.","volume":"207","author":"Lutgens","year":"2010","journal-title":"J. Exp. Med."},{"key":"B113","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1161\/CIRCRESAHA.116.304937","article-title":"Mechanotransduction in cardiac hypertrophy and failure.","volume":"116","author":"Lyon","year":"2015","journal-title":"Circ. Res."},{"key":"B114","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1161\/CIRCHEARTFAILURE.113.000713","article-title":"MuRF1 negatively regulates pathological cardiac hypertrophy through downregulation of calcineurin A.","volume":"7","author":"Maejima","year":"2014","journal-title":"Circ. Heart Fail."},{"key":"B115","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrm3495","article-title":"Molecular basis of physiological heart growth: fundamental concepts and new players.","volume":"14","author":"Maillet","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/ni1200","article-title":"ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity.","volume":"6","author":"Matsuzawa","year":"2005","journal-title":"Nat. Immunol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1126\/science.1157340","article-title":"Essential cytoplasmic translocation of a cytokine receptor\u2013assembled signaling complex.","volume":"321","author":"Matsuzawa","year":"2008","journal-title":"Science"},{"key":"B118","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1161\/01.CIR.0000130641.08705.45","article-title":"Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload.","volume":"109","author":"Mcmullen","year":"2004","journal-title":"Circulation"},{"key":"B119","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1161\/HYPERTENSIONAHA.107.097816","article-title":"Suppression of cardiomyocyte hypertrophy by inhibition of the ubiquitin-proteasome system.","volume":"51","author":"Meiners","year":"2008","journal-title":"Hypertension"},{"key":"B120","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1242\/jcs.091777","article-title":"HECT and RING finger families of E3 ubiquitin ligases at a glance.","volume":"125","author":"Metzger","year":"2012","journal-title":"J. Cell Sci."},{"key":"B121","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.bbamcr.2013.05.026","article-title":"RING-type E3 ligases: master manipulators of E2 ubiquitin-conjugating enzymes and ubiquitination.","volume":"1843","author":"Metzger","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"B122","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1161\/circresaha.110.219295","article-title":"TRAF5 deficiency accelerates atherogenesis in mice by increasing inflammatory cell recruitment and foam cell formation.","volume":"107","author":"Missiou","year":"2010","journal-title":"Circ. Res."},{"key":"B123","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0378-1119(97)00616-1","article-title":"Cloning and characterization of a cDNA encoding the human homolog of tumor necrosis factor receptor-associated factor 5 (TRAF5).","volume":"207","author":"Mizushima","year":"1998","journal-title":"Gene"},{"key":"B124","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0378-1119(99)00487-4","article-title":"MDM2\u2014master regulator of the p53 tumor suppressor protein.","volume":"242","author":"Momand","year":"2000","journal-title":"Gene"},{"key":"B125","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/0092-8674(92)90644-R","article-title":"The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.","volume":"69","author":"Momand","year":"1992","journal-title":"Cell"},{"key":"B126","doi-asserted-by":"publisher","first-page":"10722","DOI":"10.1021\/bi800733z","article-title":"Structural analysis of B-Box 2 from MuRF1: identification of a novel self-association pattern in a RING-like fold.","volume":"47","author":"Mrosek","year":"2008","journal-title":"Biochemistry"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1332","article-title":"TRAF6 ubiquitinates TGF\u03b2 type I receptor to promote its cleavage and nuclear translocation in cancer.","volume":"2","author":"Mu","year":"2011","journal-title":"Nat. Commun."},{"key":"B128","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/nm1574","article-title":"The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress.","volume":"13","author":"Nakai","year":"2007","journal-title":"Nat. Med."},{"key":"B129","doi-asserted-by":"publisher","first-page":"14661","DOI":"10.1074\/jbc.271.25.14661","article-title":"TRAF5, an activator of NF-\u03baB and putative signal transducer for the lymphotoxin-\u03b2 receptor.","volume":"271","author":"Nakano","year":"1996","journal-title":"J. Biol. Chem."},{"key":"B130","doi-asserted-by":"publisher","first-page":"9803","DOI":"10.1073\/pnas.96.17.9803","article-title":"Targeted disruption of Traf5 gene causes defects in CD40- and CD27-mediated lymphocyte activation.","volume":"96","author":"Nakano","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B131","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1006\/geno.1997.4697","article-title":"Human TNF receptor-associated factor 5 (TRAF5): cDNA cloning, expression and assignment of the TRAF5 gene to chromosome 1q32.","volume":"42","author":"Nakano","year":"1997","journal-title":"Genomics"},{"key":"B132","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0305-7372(03)00083-5","article-title":"Therapeutic anti-cancer targets upstream of the proteasome.","volume":"29","author":"Nalepa","year":"2003","journal-title":"Cancer Treat. Rev."},{"key":"B133","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S1534-5807(04)00020-6","article-title":"Ozz-E3, a muscle-specific ubiquitin ligase, regulates \u03b2-catenin degradation during myogenesis.","volume":"6","author":"Nastasi","year":"2004","journal-title":"Dev. Cell"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006049","article-title":"Signaling in innate immunity and inflammation.","volume":"4","author":"Newton","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1161\/hc0402.102990","article-title":"Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly.","volume":"105","author":"Niimura","year":"2002","journal-title":"Circulation"},{"key":"B136","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.cell.2005.11.007","article-title":"A genomic and functional inventory of deubiquitinating enzymes.","volume":"123","author":"Nijman","year":"2005","journal-title":"Cell"},{"key":"B137","doi-asserted-by":"publisher","first-page":"9220","DOI":"10.1128\/MCB.01453-06","article-title":"Autophagy is activated for cell survival after endoplasmic reticulum stress.","volume":"26","author":"Ogata","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"B138","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/j.1365-2141.2007.06659.x","article-title":"Unexpected cardiotoxicity in haematological bortezomib treated patients.","volume":"138","author":"Orciuolo","year":"2007","journal-title":"Br. J. Haematol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/43466","article-title":"NF-\u03baB activation by tumour necrosis factor requires the Akt serine\u2013threonine kinase.","volume":"401","author":"Ozes","year":"1999","journal-title":"Nature"},{"key":"B140","doi-asserted-by":"publisher","first-page":"4955","DOI":"10.1158\/0008-5472.CAN-14-1211","article-title":"Emerging potential of therapeutic targeting of ubiquitin-specific proteases in the treatment of cancer.","volume":"74","author":"Pal","year":"2014","journal-title":"Cancer Res."},{"key":"B141","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1016\/j.bbadis.2016.07.002","article-title":"Cardiac ubiquitin ligases: their role in cardiac metabolism, autophagy, cardioprotection and therapeutic potential.","volume":"1862","author":"Parry","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"B142","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1002\/bies.20852","article-title":"Dysfunction of the ubiquitin\u2013proteasome system in multiple disease conditions: therapeutic approaches.","volume":"30","author":"Paul","year":"2008","journal-title":"Bioessays"},{"key":"B143","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1038\/nm.3739","article-title":"Ubiquitination in disease pathogenesis and treatment.","volume":"20","author":"Popovic","year":"2014","journal-title":"Nat. Med."},{"key":"B144","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1161\/CIRCULATIONAHA.109.904557","article-title":"Ubiquitin proteasome dysfunction in human hypertrophic and dilated cardiomyopathies.","volume":"121","author":"Predmore","year":"2010","journal-title":"Circulation"},{"key":"B145","doi-asserted-by":"publisher","first-page":"6668","DOI":"10.1073\/pnas.111155798","article-title":"Activation of NF-\u03baB is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes.","volume":"98","author":"Purcell","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B146","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nrm.2017.83","article-title":"Ubiquitylation at the crossroads of development and disease.","volume":"19","author":"Rape","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"676","DOI":"10.7326\/0003-4819-145-9-200611070-00010","article-title":"Narrative review: protein degradation and human diseases: the ubiquitin connection.","volume":"145","author":"Reinstein","year":"2006","journal-title":"Ann. Intern. Med."},{"key":"B148","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1146\/annurev.biochem.78.082307.091526","article-title":"Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes.","volume":"78","author":"Reyes-Turcu","year":"2009","journal-title":"Annu. Rev. Biochem."},{"key":"B149","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1056\/NEJMoa043445","article-title":"Bortezomib or high-dose dexamethasone for relapsed multiple myeloma.","volume":"352","author":"Richardson","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"B150","first-page":"39","article-title":"MuRF1 and MuRF2 are necessary but functionally redundant during developmental cardiac growth in vivo.","volume":"32","author":"Rodriguez","year":"2009","journal-title":"Am. Heart Assoc."},{"key":"B151","doi-asserted-by":"crossref","first-page":"164","DOI":"10.25004\/IJPSDR.2012.040301","article-title":"Cardiac hypertrophy: a review on pathogenesis and treatment.","volume":"4","author":"Rohilla","year":"2012","journal-title":"Int. J. Pharm. Sci. Drug Res."},{"key":"B152","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/nature05602","article-title":"p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload.","volume":"446","author":"Sano","year":"2007","journal-title":"Nature"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2350-11-89","article-title":"Nuclear Factor (NF) \u03baB polymorphism is associated with heart function in patients with heart failure.","volume":"11","author":"Santos","year":"2010","journal-title":"BMC Med. Genet."},{"key":"B154","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/373081a0","article-title":"Protein ubiquitination involving an E1\u2013E2\u2013E3 enzyme ubiquitin thioester cascade.","volume":"373","author":"Scheffner","year":"1995","journal-title":"Nature"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-011-0235-3","article-title":"Defective proteolytic systems in Mybpc3-targeted mice with cardiac hypertrophy.","volume":"107","author":"Schlossarek","year":"2012","journal-title":"Basic Res. Cardiol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.yjmcc.2013.12.016","article-title":"Ubiquitin-proteasome system and hereditary cardiomyopathies.","volume":"71","author":"Schlossarek","year":"","journal-title":"J. Mol. Cell Cardiol."},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2014.00484","article-title":"Proteasome inhibition slightly improves cardiac function in mice with hypertrophic cardiomyopathy.","volume":"5","author":"Schlossarek","year":"","journal-title":"Front. Physiol."},{"key":"B158","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1093\/hmg\/ddm237","article-title":"Identification of TRAF6-dependent NEMO polyubiquitination sites through analysis of a new NEMO mutation causing incontinentia pigmenti.","volume":"16","author":"Sebban-Benin","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"B159","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.bbamem.2013.07.011","article-title":"The physiological role of cardiac cytoskeleton and its alterations in heart failure.","volume":"1838","author":"Sequeira","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"B160","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1111\/j.1476-5381.2009.00605.x","article-title":"Tetrandrine blocks cardiac hypertrophy by disrupting reactive oxygen species-dependent ERK1\/2 signalling.","volume":"159","author":"Shen","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"B161","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1517\/14728222.2013.815728","article-title":"Targeting the ubiquitin\u2013proteasome system for cancer therapy.","volume":"17","author":"Shen","year":"2013","journal-title":"Expert Opin. Ther. Targets"},{"key":"B162","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/cr.2010.161","article-title":"A single NF\u03baB system for both canonical and non-canonical signaling.","volume":"21","author":"Shih","year":"2011","journal-title":"Cell Res."},{"key":"B163","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.yjmcc.2016.06.001","article-title":"Physiological and pathological cardiac hypertrophy.","volume":"97","author":"Shimizu","year":"2016","journal-title":"J. Mol. Cell Cardiol."},{"key":"B164","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1093\/emboj\/19.11.2537","article-title":"The conserved phosphoinositide 3-kinase pathway determines heart size in mice.","volume":"19","author":"Shioi","year":"2000","journal-title":"EMBO J."},{"key":"B165","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1161\/01.CIR.0000057979.36322.88","article-title":"Rapamycin attenuates load-induced cardiac hypertrophy in mice.","volume":"107","author":"Shioi","year":"2003","journal-title":"Circulation"},{"key":"B166","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1172\/JCI24682","article-title":"Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure.","volume":"115","author":"Shiojima","year":"2005","journal-title":"J. Clin. Invest."},{"key":"B167","doi-asserted-by":"publisher","first-page":"5059","DOI":"10.1128\/JVI.75.11.5059-5068.2001","article-title":"Activation of TRAF5 and TRAF6 signal cascades negatively regulates the latent replication origin of Epstein-Barr virus through p38 mitogen-activated protein kinase.","volume":"75","author":"Shirakata","year":"2001","journal-title":"J. Virol."},{"key":"B168","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1369\/jhc.7A7249.2007","article-title":"RACK1, a PKC targeting protein, is exclusively localized to basal airway epithelial cells.","volume":"56","author":"Slager","year":"2008","journal-title":"J. Histochem. Cytochem."},{"key":"B169","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1042\/BJ20140006","article-title":"RBR E3 ubiquitin ligases: new structures, new insights, new questions.","volume":"458","author":"Spratt","year":"2014","journal-title":"Biochem. J."},{"key":"B170","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1006\/bbrc.2002.6476","article-title":"Inhibition of the ubiquitin-proteasome pathway induces differential heat-shock protein response in cardiomyocytes and renders early cardiac protection.","volume":"291","author":"Stangl","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B171","doi-asserted-by":"publisher","first-page":"H645","DOI":"10.1152\/ajpheart.00196.2007","article-title":"Proteasome inhibition promotes regression of left ventricular hypertrophy.","volume":"294","author":"Stansfield","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B172","doi-asserted-by":"publisher","first-page":"9302","DOI":"10.3390\/ijms15069302","article-title":"Rare variants in genes encoding MuRF1 and MuRF2 are modifiers of hypertrophic cardiomyopathy.","volume":"15","author":"Su","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"B173","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1161\/01.RES.84.6.633","article-title":"Signaling in myocardial hypertrophy: life after calcineurin?","volume":"84","author":"Sugden","year":"1999","journal-title":"Circ. Res."},{"key":"B174","doi-asserted-by":"publisher","first-page":"36530","DOI":"10.1074\/jbc.M104837200","article-title":"Critical roles of TRAF2 and TRAF5 in tumor necrosis factor-induced NF-\u03baB activation and protection from cell death.","volume":"276","author":"Tada","year":"2001","journal-title":"J. Biol. Chem."},{"key":"B175","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/S1097-2765(00)80244-0","article-title":"TAB 2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway.","volume":"5","author":"Takaesu","year":"2000","journal-title":"Mol. Cell."},{"key":"B176","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1083\/jcb.200911078","article-title":"Endogenous HMGB1 regulates autophagy.","volume":"190","author":"Tang","year":"2010","journal-title":"J. Cell Biol."},{"key":"B177","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1093\/cvr\/cvq217","article-title":"Proteasome functional insufficiency activates the calcineurin\u2013NFAT pathway in cardiomyocytes and promotes maladaptive remodelling of stressed mouse hearts.","volume":"88","author":"Tang","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"B178","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.bbrc.2006.04.108","article-title":"MDM2 interacts with and downregulates a sarcomeric protein, TCAP.","volume":"345","author":"Tian","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B179","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.semcdb.2015.10.017","article-title":"TRIM-NHL proteins in development and disease.","author":"Tocchini","year":"2015","journal-title":"Semin. Cell Dev. Biol."},{"key":"B180","doi-asserted-by":"publisher","first-page":"3679","DOI":"10.1074\/jbc.M509630200","article-title":"Differential regulation of cardiomyocyte survival and hypertrophy by MDM2, an E3 ubiquitin ligase.","volume":"281","author":"Toth","year":"2006","journal-title":"J. Biol. Chem."},{"key":"B181","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/nature01803","article-title":"CYLD is a deubiquitinating enzyme that negatively regulates NF-\u03baB activation by TNFR family members.","volume":"424","author":"Trompouki","year":"2003","journal-title":"Nature"},{"key":"B182","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.bbrc.2005.12.120","article-title":"Depression of proteasome activities during the progression of cardiac dysfunction in pressure-overloaded heart of mice.","volume":"340","author":"Tsukamoto","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2017.00151","article-title":"E3 ubiquitin ligases neurobiological mechanisms: development to degeneration.","volume":"10","author":"Upadhyay","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"B184","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1126\/science.287.5453.664","article-title":"Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1.","volume":"287","author":"Urano","year":"2000","journal-title":"Science"},{"key":"B185","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1038\/ni.1678","article-title":"Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-\u03baB signaling.","volume":"9","author":"Vallabhapurapu","year":"2008","journal-title":"Nat. Immunol."},{"key":"B186","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev-biochem-061516-044859","article-title":"The ubiquitin system, autophagy, and regulated protein degradation.","volume":"86","author":"Varshavsky","year":"2017","journal-title":"Annu. Rev. Biochem."},{"key":"B187","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.1038\/emboj.2012.240","article-title":"A20 inhibits LUBAC-mediated NF-\u03baB activation by binding linear polyubiquitin chains via its zinc finger 7.","volume":"31","author":"Verhelst","year":"2012","journal-title":"EMBO J."},{"key":"B188","doi-asserted-by":"publisher","first-page":"734","DOI":"10.15252\/embr.201439014","article-title":"A20: attractive without showing cleavage.","volume":"15","author":"Verhelst","year":"2014","journal-title":"EMBO Rep."},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-6-129","article-title":"Severe reversible cardiac failure after bortezomib treatment combined with chemotherapy in a non-small cell lung cancer patient: a case report.","volume":"6","author":"Voortman","year":"2006","journal-title":"BMC Cancer"},{"key":"B190","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1530\/JME-15-0283","article-title":"MuRF1 mono-ubiquitinates TR\u03b1 to inhibit T3-induced cardiac hypertrophy in vivo.","volume":"56","author":"Wadosky","year":"2016","journal-title":"J. Mol. Endocrinol."},{"key":"B191","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.yjmcc.2015.04.012","article-title":"Deubiquitinating enzyme CYLD mediates pressure overload-induced cardiac maladaptive remodeling and dysfunction via downregulating Nrf2.","volume":"84","author":"Wang","year":"2015","journal-title":"J. Mol. Cell Cardiol."},{"key":"B192","first-page":"255","article-title":"The ubiquitin-proteasome system and its role in inflammatory and autoimmune diseases.","volume":"3","author":"Wang","year":"2006","journal-title":"Cell Mol. Immunol."},{"key":"B193","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/hr.2011.196","article-title":"Angiotensin II-induced cardiomyocyte hypertrophy in vitro is TAK1-dependent and Smad2\/3-independent.","volume":"35","author":"Watkins","year":"2012","journal-title":"Hypertens. Res."},{"key":"B194","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/nature02794","article-title":"De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling.","volume":"430","author":"Wertz","year":"2004","journal-title":"Nature"},{"key":"B195","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.bbrc.2004.07.121","article-title":"Calcium\u2013calcineurin signaling in the regulation of cardiac hypertrophy.","volume":"322","author":"Wilkins","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B196","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1242\/jcs.041046","article-title":"DUBs at a glance.","volume":"122","author":"Wilkinson","year":"2009","journal-title":"J. Cell Sci."},{"key":"B197","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.bbamcr.2004.09.027","article-title":"A hitchhiker\u2019s guide to the cullin ubiquitin ligases: SCF and its kin.","volume":"1695","author":"Willems","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"B198","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.yjmcc.2006.07.015","article-title":"Into the heart: the emerging role of the ubiquitin\u2013proteasome system.","volume":"41","author":"Willis","year":"2006","journal-title":"J. Mol. Cell Cardiol."},{"key":"B199","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1161\/CIRCRESAHA.109.208801","article-title":"Sent to destroy: the ubiquitin proteasome system regulates cell signaling and protein quality control in cardiovascular development and disease.","volume":"106","author":"Willis","year":"2010","journal-title":"Circ. Res."},{"key":"B200","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.jmb.2005.05.021","article-title":"MURF-1 and MURF-2 target a specific subset of myofibrillar proteins redundantly: towards understanding MURF-dependent muscle ubiquitination.","volume":"350","author":"Witt","year":"2005","journal-title":"J. Mol. Biol."},{"key":"B201","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/pro.2415","article-title":"Mechanisms for regulating deubiquitinating enzymes.","volume":"23","author":"Wolberger","year":"2014","journal-title":"Protein Sci."},{"key":"B202","doi-asserted-by":"publisher","first-page":"6783","DOI":"10.1074\/jbc.M709496200","article-title":"Essential role of SQSTM1\/p62 in regulating accumulation of K63-ubiquitinated proteins.","volume":"283","author":"Wooten","year":"2008","journal-title":"J. Biol. Chem."},{"key":"B203","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1002\/bies.10352","article-title":"TRAF6, a molecular bridge spanning adaptive immunity, innate immunity and osteoimmunology.","volume":"25","author":"Wu","year":"2003","journal-title":"Bioessays"},{"key":"B204","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/j.chembiol.2012.09.015","article-title":"Specific small molecule inhibitors of Skp2-mediated p27 degradation.","volume":"19","author":"Wu","year":"2012","journal-title":"Chem. Biol."},{"key":"B205","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/nature08247","article-title":"Direct activation of protein kinases by unanchored polyubiquitin chains.","volume":"461","author":"Xia","year":"2009","journal-title":"Nature"},{"key":"B206","doi-asserted-by":"publisher","first-page":"6474","DOI":"10.1073\/pnas.1016132108","article-title":"I\u03baB kinase \ud835\udf00 and TANK-binding kinase 1 activate AKT by direct phosphorylation.","volume":"108","author":"Xie","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076016","article-title":"SQSTM1\/p62 interacts with HDAC6 and regulates deacetylase activity.","volume":"8","author":"Yan","year":"2013","journal-title":"PLoS One"},{"key":"B208","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1161\/HYPERTENSIONAHA.116.07562","article-title":"Novel protective role for ubiquitin-specific protease 18 in pathological cardiac remodeling.","volume":"68","author":"Ying","year":"2016","journal-title":"Hypertension"},{"key":"B209","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/978-3-319-55330-6_17","article-title":"\u201cMitochondrial ubiquitin ligase in cardiovascular disorders,\u201d in","author":"Yu","year":"2017","journal-title":"Mitochondrial Dynamics in Cardiovascular Medicine. Advances in Experimental Medicine and Biology"},{"key":"B210","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1021\/ci500631e","article-title":"Discovery of small molecule CD40\u2013TRAF6 inhibitors.","volume":"55","author":"Zarzycka","year":"2015","journal-title":"J. Chem. Inform. Model."},{"key":"B211","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1093\/cvr\/cvp237","article-title":"NF-\u03baB activation is required for adaptive cardiac hypertrophy.","volume":"84","author":"Zelarayan","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"B212","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/75037","article-title":"TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice.","volume":"6","author":"Zhang","year":"2000","journal-title":"Nat. Med."},{"key":"B213","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ebiom.2016.12.014","article-title":"Regulation of XIAP turnover reveals a role for USP11 in promotion of tumorigenesis.","volume":"15","author":"Zhou","year":"2017","journal-title":"EBioMedicine"},{"key":"B214","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.cardiores.2005.12.021","article-title":"The ubiquitin\u2013proteasome system: focus on the heart.","volume":"70","author":"Zolk","year":"2006","journal-title":"Cardiovasc. Res."}],"updated-by":[{"DOI":"10.3389\/fgene.2018.00409","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T00:00:00Z","timestamp":1537315200000}}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fgene.2018.00336\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T12:46:58Z","timestamp":1751806018000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fgene.2018.00336\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,21]]},"references-count":214,"alternative-id":["10.3389\/fgene.2018.00336"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2018.00336","relation":{"corrigendum":[{"id-type":"doi","id":"10.3389\/fgene.2018.00409","asserted-by":"object"}]},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,21]]},"article-number":"336"}}